Christopher Hite - 05 Nov 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP & Vice Chairman
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite
Issuer symbol
RPRX
Transactions as of
05 Nov 2025
Net transactions value
$0
Form type
4
Filing time
07 Nov 2025, 16:18:10 UTC
Previous filing
08 Aug 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hite Christopher EVP & Vice Chairman C/O ROYALTY PHARMA PLC, 110 E. 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite 07 Nov 2025 0001814238

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +6,168 +0.95% $0.000000 658,510 05 Nov 2025 By SCH Investment Partners LLC F1
holding RPRX Class A Ordinary Shares 70,000 05 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.